相关实验视频
Updated: Jul 6, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.4K
皮质类固醇诱导的神经病变
Andreia Coutinho1, Núria Fonseca1, Isabel Novo1
1Internal Medicine, Centro Hospitalar do Médio Ave, Santo Tirso, PRT.
Cureus
|December 29, 2023
概括
皮质类固醇诱导肌肉病,一种常见的药物副作用,表现为肌肉虚弱和酶升高. 肌肉活检证实了在患有拉布地质溶解和急性损伤的患者的诊断.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 病理学 病理学 病理学
背景情况:
- 皮质类固醇诱导肌肉病是最常见的药物诱导肌肉病.
- 它可能发生在需要长期皮质类固醇治疗的患者中.
研究的目的:
- 为了呈现一种皮质类固醇诱导肌肉病变的临床病例.
- 突出诊断挑战和肌肉活检的作用.
主要方法:
- 临床病例的介绍.
- 审查患者的症状,实验室发现和诊断程序.
- 肌肉活检用于确定诊断.
主要成果:
- 患者表现出近端肌肉衰弱,肌痛和肌肉酶的升高.
- 观察到二次性拉布多米解的急性损伤.
- 肌肉活检对于确认诊断至关重要.
结论:
- 皮质类固醇诱导的肌肉病需要高度的临床怀疑.
- 肌肉活检在模两可的情况下仍然是确定诊断的必要条件.
- 早期识别和管理至关重要,以防止诸如骨髓溶解之类的并发症.
相关概念视频
Disorders of the Skeletal Muscle
955
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
955
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Myasthenia Gravis: Diagnostic Tests
861
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
861
Skeletal Muscle Relaxants: Adverse Effects
373
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
373
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120

